|
|
Article: A changing framework for MS treatment: more choices mean more responsibility.(I want you to know)
- Article from:
- Inside MS
- Article date:
- June 1, 2006
- Author:
CopyrightCOPYRIGHT 2006 National Multiple Sclerosis Society. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
For the past 12 years we have been extremely fortunate that the FDA-approved agents for treating MS have been extraordinarily safe. Similar degrees of safety are not seen among the medications available for treatment of most other autoimmune diseases. While we are grateful for the degree of efficacy provided by our currently available drugs, there is need for improvement. Such improvement is likely to come from both the use of combinations of existing medications and the development of entirely new drugs.
Among the medications approved by the FDA for use in autoimmune diseases such as rheumatoid arthritis, Crohn's disease, systemic lupus erythematosus, psoriasis, ...